| ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males (NCT00277095) | Uromedica | 2005-08-01 |
| A Research Study for Patients With Overactive Bladder (NCT00168454) | Allergan | 2005-07-01 |
| ATLAS: Ambulatory Treatments for Leakage Associated With Stress (NCT00270998) | NICHD Pelvic Floor Disorders Network | 2005-06-01 |
| Randomized Trial for Botox Urinary Incontinence (NCT00178191) | University of Rochester | 2005-06-01 |
| Low-Intensity Physical Therapy for Prevention of Pre and Postpartum Urinary Incontinence (NCT00178282) | University of Rochester | 2005-06-01 |
| Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet (NCT00139724) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-05-01 |
| Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women (NCT00143481) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-03-01 |
| Programmable Timer in the Bladder Rehabilitation Treatment of OAB (NCT00238680) | University of Aarhus | 2005-03-01 |
| Evaluation of the Efficacy and Safety of Advantage® Strips in Women Stress Urinary Incontinence (SUI ) (NCT02927548) | Centre Hospitalier Universitaire de Nīmes | 2005-01-01 |
| Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate (NCT00632138) | Aberdeen Royal Infirmary | 2005-01-01 |
| Outcomes of Anterior Colporrhaphy Versus Graft Reinforced Anterior Prolapse Repair (NCT00535301) | Kaiser Permanente | 2005-01-01 |
| Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity (NCT01530620) | APOGEPHA Arzneimittel GmbH | 2004-12-01 |
| A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder (NCT00137397) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2004-11-01 |
| Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder (NCT00196404) | Duramed Research | 2004-10-01 |
| Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB (NCT00143377) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2004-09-01 |
| Program to Reduce Incontinence by Diet and Exercise (NCT00091988) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2004-07-01 |
| Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence (NCT00603343) | APOGEPHA Arzneimittel GmbH | 2004-06-01 |
| Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder (NCT00224146) | Watson Pharmaceuticals | 2004-05-01 |
| Long-term Effectiveness of Abdominal Sacrocolpopexy for the Treatment of Pelvic Organ Prolapse (NCT00099372) | NICHD Pelvic Floor Disorders Network | 2004-05-01 |
| InterStim Prospective Database (NCT00441935) | Kenneth Peters, MD | 2004-04-01 |
| Burden of Urinary Incontinence in Home Care Patients in the State of Geneva (NCT00530036) | University Hospital, Geneva | 2004-01-01 |
| Enhancing Conservative Treatment for Urge Incontinence (NCT00223821) | US Department of Veterans Affairs | 2003-09-01 |
| Conservative Treatment of Postprostatectomy Incontinence (NCT00212264) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-08-01 |
| ORWH:SCOR on Sex and Gender Factors Affecting Women's Incontinence (NCT00069368) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-07-01 |
| An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence (NCT00080470) | Boston Scientific Corporation | 2003-06-01 |
| IRIS: Incontinence Research Intervention Study (NCT00125177) | University of Michigan | 2003-01-01 |
| Urge Incontinence Bladder Overactivity Study (NCT00475696) | Eli Lilly and Company | 2002-11-01 |
| Predictive Objective Parameters for Outcome of the Treatment of Stress Urinary Incontinence (NCT00658944) | University Of Perugia | 2002-05-01 |
| Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence (NCT00064662) | Carelon Research | 2002-02-01 |
| Pelvic Organ Prolapse Repair With or Without Concomitant Burch Colposuspension in Patients With Urinary Incontinence (NCT00576004) | University Of Perugia | 2002-01-01 |
| Adjustable Continence Therapy (ACT) Device for the Treatment of Female Stress Urinary Incontinence (NCT00113555) | Uromedica | 2001-12-01 |
| A 3 Year Follow-up Prospective Open Randomized Trial of TVT Versus Colposuspension for Primary Stress Incontinence (NCT00782990) | Hospital Severo Ochoa | 2001-01-01 |
| Prevent Inability To Control Urination (NCT00075114) | University of Michigan | 2000-09-01 |
| Effect of Pelvic Floor Muscle Training in Stroke (NCT00258037) | Glostrup University Hospital, Copenhagen | 1999-01-01 |
| A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary Incontinence (NCT00269724) | Alza Corporation, DE, USA | 1997-03-01 |
| Promoting Effective Recovery From Labor Urinary Incontinence (PERL) (NCT00506116) | University of Michigan | 1996-07-01 |
| Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence (NCT00304499) | Alza Corporation, DE, USA | 1995-12-01 |
| Use of Complementary and Alternative Medicine Among Older Mexican Americans (NCT00084110) | National Center for Complementary and Integrative Health (NCCIH) | 1993-08-01 |
| Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive Bladder (NCT00293839) | Alza Corporation, DE, USA | |
| Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach. (NCT00262496) | US Department of Veterans Affairs | |